As New Zealand emerges from its Omicron wave, increasing hybrid immunity and access to antivirals mean it’s time to shift the focus of COVID management.
- Associate Professor Immunology and Microbiology and Clinical Microbiologist, University of Otago
Contact James for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- Joined
